Oppenheimer Asset Management Inc. Veracyte, Inc. Transaction History

Oppenheimer Asset Management Inc.

$7.62 Billion
Q2 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 9,333 shares of VCYT stock, worth $315,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,333

Previous 9,370 0.39%

Holding current value

$315,175

Previous $207,000 2.42%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$18.86 - $23.55 $697 - $871	-37 Reduced 0.39%	9,333 $202,000
Q1 2024 May 06, 2024	SELL	$21.0 - $29.1 $6,615 - $9,166	-315 Reduced 3.25%	9,370 $207,000
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $4,791 - $6,969	-243 Reduced 2.45%	9,685 $266,000
Q3 2023 Nov 07, 2023	SELL	$22.33 - $29.92 $1,853 - $2,483	-83 Reduced 0.83%	9,928 $221,000
Q2 2023 Aug 02, 2023	SELL	$20.96 - $26.99 $9,809 - $12,631	-468 Reduced 4.47%	10,011 $254,000
Q1 2023 May 10, 2023	SELL	$20.58 - $27.89 $11,607 - $15,729	-564 Reduced 5.11%	10,479 $233,000
Q4 2022 Feb 06, 2023	SELL	$15.31 - $29.94 $13,090 - $25,598	-855 Reduced 7.19%	11,043 $262,000
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $3,332 - $5,607	-201 Reduced 1.66%	11,898 $198,000
Q2 2022 Aug 08, 2022	SELL	$15.45 - $29.52 $4,310 - $8,236	-279 Reduced 2.25%	12,099 $241,000
Q1 2022 May 12, 2022	SELL	$21.94 - $42.51 $6,823 - $13,220	-311 Reduced 2.45%	12,378 $342,000
Q4 2021 Feb 02, 2022	SELL	$36.09 - $53.79 $15,410 - $22,968	-427 Reduced 3.26%	12,689 $523,000
Q3 2021 Nov 12, 2021	SELL	$35.62 - $52.97 $9,653 - $14,354	-271 Reduced 2.02%	13,116 $609,000
Q2 2021 Aug 03, 2021	SELL	$32.94 - $56.62 $2,931 - $5,039	-89 Reduced 0.66%	13,387 $536,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $18,366 - $33,609	-413 Reduced 2.97%	13,476 $724,000
Q4 2020 Feb 11, 2021	SELL	$32.49 - $61.88 $43,958 - $83,723	-1,353 Reduced 8.88%	13,889 $680,000
Q3 2020 Nov 13, 2020	SELL	$26.73 - $35.67 $7,430 - $9,916	-278 Reduced 1.79%	15,242 $495,000
Q2 2020 Aug 11, 2020	BUY	$19.49 - $28.11 $7,191 - $10,372	369 Added 2.44%	15,520 $401,000
Q1 2020 May 08, 2020	BUY	$16.13 - $30.17 $2,258 - $4,223	140 Added 0.93%	15,151 $368,000
Q4 2019 Feb 07, 2020	BUY	$20.78 - $29.99 $36,219 - $52,272	1,743 Added 13.14%	15,011 $419,000
Q3 2019 Oct 31, 2019	SELL	$23.87 - $30.93 $5,275 - $6,835	-221 Reduced 1.64%	13,268 $318,000
Q2 2019 Aug 09, 2019	BUY	$22.1 - $28.56 $106,919 - $138,173	4,838 Added 55.92%	13,489 $385,000
Q1 2019 Apr 24, 2019	SELL	$12.0 - $25.76 $57,588 - $123,622	-4,799 Reduced 35.68%	8,651 $216,000
Q4 2018 Jan 30, 2019	BUY	$9.15 - $14.85 $123,067 - $199,732	13,450 New	13,450 $169,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Veracyte, Inc. Transaction History